Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/02/2010WO2010138527A1 Analytical methods for measuring synthetic progesterone
12/02/2010WO2010138496A1 Iap inhibitors
12/02/2010WO2010138490A1 Benzoxazepines as inhibitors of mtor and methods of their use and manufacture
12/02/2010WO2010138488A1 Hepatitis c virus inhibitors
12/02/2010WO2010138487A1 BENZOXAZEPINES AS INHIBITORS OF PI3K/m TOR AND METHODS OF THEIR USE AND MANUFACTURE
12/02/2010WO2010138430A1 Alkoxy tetrahydro-pyridopyrimidine pde10 inhibitors
12/02/2010WO2010138421A1 HEXAHYDROCYCLOPENTYL[f]INDAZOLE REVERSED AMIDES AND DERIVATIVES AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
12/02/2010WO2010138419A2 Materials and methods for treating viral infections
12/02/2010WO2010138338A1 Hiv protease inhibitors
12/02/2010WO2010138210A1 Methods of saponifying xanthophyll esters and isolating xanthophylls
12/02/2010WO2010138141A1 Combination therapy for the treatment of multiple myeloma
12/02/2010WO2010138101A1 Combination therapy for the treatment of multiple myeloma using cep-18770 together with bortezomib or mephalan
12/02/2010WO2010138095A1 Medicinal agent
12/02/2010WO2010138084A1 CRYSTAL STRUCTURE OF CAP-FREE HUMAN eIF4E
12/02/2010WO2010138082A1 Flavonoid hydrogel
12/02/2010WO2010138074A1 Hyaluronic acid based delivery systems
12/02/2010WO2010137944A1 Treatment of hypercalcaemia
12/02/2010WO2010137888A2 Microspheres with improved bioavailability containing poorly water-soluble drugs, and method for preparing same
12/02/2010WO2010137855A2 Multi-layer tablet comprising effervescent layer
12/02/2010WO2010137738A1 Heterocyclic compounds for the treatment of stress-related conditions
12/02/2010WO2010137731A1 Pharmaceutical composition comprising prostaglandin derivatives for use in modulating claudin mediated functions and in the treatment of dermatological disorders
12/02/2010WO2010137696A1 Oral medicinal composition and oral medicinal capsule having the composition encapsulated therein
12/02/2010WO2010137689A1 Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder
12/02/2010WO2010137681A1 Prophylactic or therapeutic agent for retinal diseases comprising tranilast, method for prevention or treatment of retinal diseases, and tranilast or pharmaceutically acceptable salt thereof and use thereof
12/02/2010WO2010137620A1 Phenoxyethylamine derivative
12/02/2010WO2010137613A1 Solid preparation having improved storage stability
12/02/2010WO2010137570A1 Anti-viral agent or an anti-cancer agent
12/02/2010WO2010137484A1 Anti-shock agent comprising diaminotrifluoromethylpyridine derivative
12/02/2010WO2010137351A1 Aryl substituted carboxamide derivatives as calcium or sodium channel blockers
12/02/2010WO2010137350A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010137349A1 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
12/02/2010WO2010137336A1 NOVEL α-PHENOXYBENZENEACETIC ACID DERIVATIVE AND PHARMACEUTICAL PREPARATION COMPRISING SAME
12/02/2010WO2010137335A1 TURN-OVER-ACCELERATING COMPOSITION CONTAINING α-LIPOIC ACID NANOPARTICLES
12/02/2010WO2010137160A1 Prophylactic or therapeutic agent for pulmonary fibrosis
12/02/2010WO2010137131A1 Stable lyophilized preparation comprising anthracycline compound
12/02/2010WO2010137027A1 Solid oral dosage forms of lamivudine
12/02/2010WO2010137018A1 Piperazine, piperidine and tetrahydropyridine derivatives and their pharmaceutical use
12/02/2010WO2010136971A1 Ketolide compounds having antimicrobial activity
12/02/2010WO2010136964A1 Method of treating sleep disorders using the combination of eplivanserin and zolpidem
12/02/2010WO2010136952A2 Self-microemulsifying mitotane composition
12/02/2010WO2010136940A1 Novel glucocorticoid receptor agonists
12/02/2010WO2010136895A1 Solid state forms of paliperidone salts and process for the preparation thereof
12/02/2010WO2010136872A2 Use of a glycosaminoglycan fixed combination and chewable composition comprising said fixed combination
12/02/2010WO2010136847A1 Coated metformin with pioglitazone solution
12/02/2010WO2010136846A1 Differentiation therapy for sarcomas
12/02/2010WO2010136839A1 Use of deferoxamine and related compounds in targeted delivery forms to treat an inflammatory bowel disease
12/02/2010WO2010136823A1 Angina treatment
12/02/2010WO2010136817A1 Heterocyclic urea derivatives and methods of use thereof
12/02/2010WO2010136804A1 Pyrimidine derivatives for use as antibiotics
12/02/2010WO2010136803A1 Methods of enhancing selective serotonin reuptake inhibitor effects in mammals
12/02/2010WO2010136778A1 Dibenzothiophene derivatives as dna- pk inhibitors
12/02/2010WO2010136755A1 Substituted benzotriazines and quinoxalines as inhibitors of p7os6 kinase
12/02/2010WO2010136742A1 Method of preventing diarrhoea
12/02/2010WO2010136740A1 Method for preparing hollow particles, and uses thereof
12/02/2010WO2010136705A1 Pharmaceutical antitumor composition including a cdk inhibitor and a cell-growth inhibitor
12/02/2010WO2010136594A2 Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
12/02/2010WO2010136592A1 Derivatives of ursodeoxycholic acid for the treatment of diarrhoea
12/02/2010WO2010136589A1 Treatment of tissue adhesion
12/02/2010WO2010136570A1 Green tea extracts of improved bioavailability
12/02/2010WO2010136559A1 2, 4 -diaminopyrimidines for the treatment of diseases characterised by excessive or abnormal cell proliferation
12/02/2010WO2010136546A1 3-alkyl-5-fluoroindole derivatives as myeloperoxidase inhibitors
12/02/2010WO2010136526A1 Resolution of (±)-methyl phenyl[4-[4-[[[4'-(trifluoromethyl)-2-biphenylyl]carbonyl]amino]phenyl]-1-piperidinyl]acetate
12/02/2010WO2010136500A1 Process for the production of benzofurans
12/02/2010WO2010136493A1 Substituted aminopropionic derivatives as neprilysin inhibitors
12/02/2010WO2010136491A1 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010WO2010136449A1 Akg composition and use thereof in the production of a drug
12/02/2010WO2010136438A1 (dihydro) imidazoiso (5, 1-a) quinolines as fsh receptor agonists for the treatment of fertility disorders
12/02/2010WO2010136394A1 Therapeutic combination comprising a plk1 inhibitor and an antineoplastic agent
12/02/2010WO2010136221A1 Dodeca-2e,4e-diene amides and their use as medicaments and cosmetics
12/02/2010WO2010136149A1 Transdermal therapeutic system having controlled active substance flow comprising a basic reacting oxide
12/02/2010WO2010136145A1 Pyrazinylpyrazoles
12/02/2010WO2010136144A1 Substituted piperidines
12/02/2010WO2010136138A1 Substituted piperidines
12/02/2010WO2010136137A1 Substituted piperidines
12/02/2010WO2010136127A1 Substituted 3-(1,2,4-oxadiazol-5-yl)-5-phenylpiperidines
12/02/2010WO2010136105A2 Ammoniumcarboxylates
12/02/2010WO2010136037A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
12/02/2010WO2010135976A1 1-(substituted benzyl)-5-trifluoromethyl-2-(1h) pyridone compounds and their salts, their preparation methods and use thereof
12/02/2010WO2010135972A1 Preparation methods and uses of 1-(substituted aryl)-5-trifluoromethyl-2-(1h)-pyridone compounds and their salts
12/02/2010WO2010135944A1 Salts of methyl (r)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1-carboxylate
12/02/2010WO2010135918A1 Didanosine precursor drug and its preparation method
12/02/2010WO2010135908A1 N-(2-amino-4-pyridyl) benzamide derivatives and uses thereof
12/02/2010WO2010135798A1 Use of telocinobufagin as an analgesic in the treatment of acute and chronic pains; pharmaceutical composition containing telocinobufagin and its use
12/02/2010WO2010135759A1 Novel anthraquinone derivatives
12/02/2010WO2010135758A1 Use of anthracene derivatives as anti-infectives
12/02/2010WO2010120695A3 5-ht4 receptor agonist compounds for treatment of cognitive disorders
12/02/2010WO2010117738A3 Solid state forms of sitagliptin salts
12/02/2010WO2010117346A3 Stable pharmaceutical compositions with high bioavailability
12/02/2010WO2010117091A3 Antimycotic pharmaceutical composition
12/02/2010WO2010116386A3 Novel polymorph of eletriptan hydrobromide and process for the preparation thereof
12/02/2010WO2010115825A3 Modulation of adipose triglyceride lipase for prevention and treatment of cachexia, loss of weight and muscle atrophy and methods of screening therefor
12/02/2010WO2010115741A3 New therapeutic approaches for treating neuroinflammatory conditions
12/02/2010WO2010111418A3 Process for the production of fused, tricyclic sulfonamides
12/02/2010WO2010109212A3 Carrier comprising a vitamin e derivative
12/02/2010WO2010108251A3 Antineoplastic testosterone molecular complex
12/02/2010WO2010107957A3 RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/02/2010WO2010106269A3 Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics
12/02/2010WO2010103547A3 Substituted fused pyrimidine compounds
12/02/2010WO2010103539A3 Sustained release oral formulation of vinpocetine
12/02/2010WO2010103017A3 Hapten-carrier conjugates with bacterial toxins having a signal peptide as carrier and their use in immunogenic compositions
1 ... 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 ... 7860